Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -276,011 | -203,350 | -137,569 | -70,972 | -239,284 |
| Depreciation Amortization | 1,149 | 565 | 455 | 208 | 776 |
| Accounts receivable | N/A | N/A | -1,179 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,231 | 3,075 | 6,821 | 7,034 | 2,806 |
| Other Working Capital | 12,543 | 10,701 | 9,672 | 6,226 | -11,073 |
| Other Operating Activity | 118,398 | 88,280 | 55,962 | 22,476 | 92,307 |
| Operating Cash Flow | $-141,690 | $-100,729 | $-65,838 | $-35,028 | $-154,468 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,284 | -6,727 | -6,662 | -44 | -1,181 |
| Purchase Of Investment | -81,794 | -81,794 | -62,727 | -36,768 | -214,806 |
| Sale Of Investment | 231,267 | 209,874 | 161,274 | 118,269 | 133,222 |
| Other Investing Activity | 0 | -3 | -2 | -1 | -3,098 |
| Investing Cash Flow | $142,189 | $121,350 | $91,883 | $81,456 | $-85,863 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 162,430 | 351 | 222 | 222 | 233,361 |
| Financing Cash Flow | $162,430 | $351 | $222 | $222 | $233,361 |
| Beginning Cash Position | 35,882 | 31,569 | 31,569 | 31,569 | 38,539 |
| End Cash Position | 198,811 | 52,541 | 57,836 | 78,219 | 31,569 |
| Net Cash Flow | $162,929 | $20,972 | $26,267 | $46,650 | $-6,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -141,690 | -100,729 | -65,838 | -35,028 | -154,468 |
| Capital Expenditure | -7,284 | -6,727 | -6,662 | -44 | -1,181 |
| Free Cash Flow | -148,974 | -107,456 | -72,500 | -35,072 | -155,649 |